ribociclib
novartis
['natalee', 'breast']
#lba500-natalee . the results of the phase iii adjuvant study for patients with hr+/her2- early breast cancer are encouraging, we will have to wait for additional follow-up #asco2023 #asco23 
Medical Oncologist at Centro Oncológico Integral, Hospital Ángeles Puebla. Cancer treatment must be personalized to the individual needs of the patient.